News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Sanofi-Aventis (France), VaxGen, Inc. HIV Vaccine Shows Promise for First Time, Study Shows
September 24, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- An experimental vaccine prevented HIV infections for the first time, a breakthrough that has eluded scientists for a quarter century.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase I
Phase III
Sanofi (France)
MORE ON THIS TOPIC
Obesity
Lilly Plots Path to FDA After Second Phase III Readout for Orforglipron
August 26, 2025
·
2 min read
·
Tristan Manalac
Rare diseases
Argenx Eyes ‘Broadest Label’ for Vyvgart in Myasthenia Gravis After Positive Phase III Data
August 26, 2025
·
2 min read
·
Tristan Manalac
Podcast
Oral Weight-Loss Race Heats Up as New Data From Lilly, Viking Reset Expectations
August 26, 2025
·
1 min read
·
Jef Akst
Regulatory
Krystal Cuts Melanoma Study of Viral Immunotherapy as FDA ‘Uncertainty’ Muddies Approval Pathway
August 22, 2025
·
2 min read
·
Tristan Manalac